Liver Cirrhosis as a Predictor of Infection Risk in Patients Undergoing Ventriculoperitoneal Shunt Surgery: A Retrospective Cohort Analysis from the Taiwan National Health Insurance Research Database (NHIRD)

肝硬化作为脑室腹腔分流术患者感染风险的预测因素:来自台湾全民健康保险研究数据库(NHIRD)的回顾性队列分析

阅读:1

Abstract

BACKGROUND Ventriculoperitoneal (VP) shunt surgery is a widely used procedure for managing hydrocephalus; however, postoperative infections remain a serious complication, increasing morbidity and mortality. Known risk factors include prior surgeries, steroid use, and concurrent procedures. However, the role of liver cirrhosis, a condition that compromises immune function and predisposes patients to infections, has not been fully investigated in the context of neurosurgery. Current literature lacks large-scale studies evaluating whether liver cirrhosis increases infection risk after VP shunt surgery. This study aims to address this gap using a nationally representative database, to compare the risk of postoperative infections in patients with and without liver cirrhosis following VP shunt surgery, utilizing data from the Taiwan National Health Insurance Research Database (NHIRD). MATERIAL AND METHODS A retrospective cohort study analyzed 1766 patients with and 37 995 patients without liver cirrhosis who underwent their first VP shunt surgery between January 2010 and December 2019. Infection risk was assessed at 6 months and 1 year after surgery. Additional factors, such as cerebral hemorrhage, aneurysm, brain tumors, decompressive craniectomy, and cranioplasty, were considered. Fine and Gray regression accounted for death as a competing risk. RESULTS After we adjusted for potential confounders, patients with cirrhosis showed a 1.41-fold increased risk of infection at 6 months (95% CI: 1.10-1.81, P=0.007) and 1.39-fold at 1 year (95% CI: 1.12-1.73, P=0.003) compared with patients without cirrhosis. CONCLUSIONS Liver cirrhosis significantly elevates infection risk following VP shunt surgery, highlighting the need for tailored perioperative strategies to improve outcomes for these patients.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。